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Introduction
Morbidity caused by neurological complications of HIV-1 
infection has become increasingly common since the im-
plementation of highly active antiretroviral therapy 
(HAART), as a result of the prolonged life expectancy of 
infected individuals. The events leading to HIV-1 brain 
infection and progression to HIV-1-associated dementia 
(HAD) are not understood. HIV-1 enters the central ner-
vous system (CNS) early during primary infection and 
can be isolated from cerebrospinal fluid (CSF) at this 
time [1]; however, viral replication in the brain is rare be-
fore the onset of immunosuppression and AIDS. Once 
infection of the brain has been established, the virus ap-
pears to undergo independent micro-evolution or com-
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Objectives: To determine the genetic and phenotypic composition of HIV-1 found in the choroid 
plexus (CPx) and its relationship to virus in the brain and peripheral lymphoid tissue.
Design: Phenotypic and molecular comparisons of HIV-1 found in autopsy brain, CPx, and 
spleen tissues.
Methods: HIV-1 was co-cultured from matched postmortem brain (basal ganglia), CPx, and 
spleen tissues of AIDS patients with and without HIV-associated encephalitis and dementia. 
Viral phenotypes were determined by infection of monocyte-derived macrophages, MT-2 or 
co-receptor-specific cell lines. Viral env and pol sequences were determined from genomic DNA 
isolated directly from tissues or co-cultures, and phylogenetic comparisons were performed.
Results: CCR5-utilization was the most prevalent viral tropism found in all tissues, although 
spleen isolates also displayed CXCR4 usage. Viruses isolated from CPx consisted of both 
peripheral and brain-like virus, but were more related phenotypically and genetically to those 
found in the brain. Mutations found in the pol gene that could confer drug resistance to brain 
and CPx isolates were similar to those found in the periphery.
Conclusion: The CPx contained replication-competent virus that was most similar, although 
distinct, from that found in the brain. It also contained some viruses with high similarity to 
those of peripheral origin. Compartmentalization of viral env and pol sequences indicated that 
differential selective pressures exist in each tissue examined. These studies suggest that the CPx 
may provide an environment that promotes the evolution of drug-resistant strains with central 
nervous system tropism, although it is unlikely to be a reservoir for archival HIV-1 variants.
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partmentalization, an effect commonly observed in other 
tissues [2–5]. Compartmentalization probably has clini-
cal implications on therapy by reducing the effectiveness 
and durability of drug treatment and vaccination strate-
gies by the sequestration of drug-resistant mutants and 
the evolution of neurotoxic quasispecies.
The choroid plexus (CPx), the main tissue involved in the 
secretion and regulation of CSF, may play a key role in 
the neuropathogenesis of HIVencephalitis (HIVE). The 
CPx consists of two fluid–cellular interfaces, one with 
capillary blood and one with CSF. The CPx endothelial 
cells express adhesion molecules that initiate lymphocyte 
migration in response to inflammation, but unlike the 
blood–brain barrier are not joined by tight junctions [6–
8]. The epithelial layer of the CPx forms the blood–CSF 
barrier of the brain; these cells are joined by tight junc-
tions and regulate the bidirectional entry of macromole-
cules, ions, cells, and perhaps virus, between the blood, 
CSF, and brain parenchyma [6, 9]. The close proximity 
of readily permissive monocytes and T cells in the CPx 
stroma implies its involvement in the transmission of vi-
rus between the CNS and peripheral compartments [10].
Previous studies have suggested that the CPx is a site 
for viral dissemination into the CNS as the viral geno-
types isolated from CPx tissues demonstrated similar-
ity with those from the peripheral and CNS compart-
ments [11, 12]. However, such studies were limited to 
formalin-fixed paraffin-embedded tissues, and we were 
thus unable to study the properties of CPx-derived vi-
rus. Accordingly, in this study, we isolated viruses from 
autopsy tissue samples of brain, CPx, and spleen from 
three AIDS patients to characterize the viral genotypes 
and phenotypes found in these three tissue compart-
ments. Our results confirm that the CPx contains a com-
posite of viruses with properties similar to those found 
in both brain and spleen tissues.
Methods
Case selection and tissue preparation
All tissues were obtained with Internal Review Board 
approval from the University of Miami according to Na-
tional Institutes of Health (NIH) guidelines. At autopsy, 
fresh brain was bisected in the mid-saggital plane and 
pieces of basal ganglia, frontal lobe and CPx from the 
trigone of the lateral ventricle were washed several times 
in phosphate-buffered saline to remove blood contami-
nation, and were rapidly frozen at 708C. Spleen tissues 
were treated similarly. Additional tissue samples from 
HIV-1-infected patients and controls were donated by 
the National NeuroAIDS Tissue Consortium in Galves-
ton, Texas, USA (MH59656) and the University of Miami 
Brain and Tissue Bank (N01 HD83284). Determination 
of HAD was based on records provided by the National 
NeuroAIDS Tissue Consortium and American Academy 
of Neurology criteria using clinical records [13]. Neu-
ropathological examination of brain tissue sections ac-
quired at the University of Miami was performed using 
hematoxylin and eosin-stained sections.
Virus Isolation
Tissue samples were thawed, washed twice with phos-
phate-buffered saline, and ground through a 100 mm 
cell strainer (BD Bioscience, USA) with the addition of 
RPMI containing 10% fetal bovine serum (Nova-tech, 
NE, USA) to obtain a tissue homogenate. Phytohemag-
glutinin-stimulated peripheral blood mononuclear cell 
(PBMC) cultures containing 10 U/ml human IL-2 were 
inoculated with the cell suspension (Roche, Indianap-
olis, IN, USA). PBMC used in the study were obtained 
from a local blood bank and were a pool of PBMC from 
two to four anonymous donors. Cells were cultured for 
5 days before replacing the media and supplementing 
with fresh uninfected phytohemagglutinin-stimulated 
PBMC. HIV-1 p24 antigen capture assays (Coulter, USA) 
of culture supernatants at 5, 10, and 15 days post-infec-
tion confirmed the production of virus from tissue ho-
mogenate co-cultures. Cell-free culture supernatants 
collected 14–21 days post-infection were used to infect 
fresh PBMC. Genomic DNA was extracted from approxi-
mately 107 first passage PBMC, or from tissue (50 mg) ac-
cording to the manufacturer’s protocol (Gentra, USA).
Virus phenotypic analyses
Co-receptor usage was determined by infecting each of 
the GHOST(3) chemokine receptor-expressing cell lines 
obtained from the NIH AIDS Reagent and Reference Re-
agent Program (i.e. CCR1, CCR2, CCR3, CCR4, CCR5, 
CCR8, CXCR4, CXCR6, CX3CR1, BOB, CCR3/CCR5/
CXCR4). Approximately 100 TCID50 of primary vi-
rus isolates (per 7.5 mm2 well) were used to infect each 
GHOST(3) cell line for 36 h before analysis by fluores-
cence microscopy. The co-receptor assay was performed 
three times independently, each in triplicate, and was 
scored qualitatively in comparison with the background 
observed for the chemokine receptor-negative GHOST(3) 
parental line.
Virus isolates were evaluated for syncytium formation 
by infection of MT-2 and C8166 T-cell lines. An assess-
ment of productive infection of macrophages was per-
formed with infection of adherent monocytes derived 
from PBMC. The culture supernatant was monitored for 
HIV-1 p24 production by antigen capture immunoassay 
(Coulter) for 15 days post-infection.
Polymerase chain reaction and sequencing
For all genetic analyses, DNA isolated from first passage 
co-cultures of tissues from the three virus-positive indi- 
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viduals plus DNA isolated directly from the three tis-
sues of two virus-negative cases were used. For env 
gene analyses, proviral DNA was amplified using the 
ED3 and ED14 primers and ED5 and ED12 primers, in 
a nested reaction as previously described [14]. Amplifi-
cation of pol sequences for resistance mutation analysis 
was performed using the JA203-206 set of nested primers 
[15]. When possible, first-round polymerase chain reac-
tion (PCR) products were cloned using the pCR4-TOPO 
TA cloning vector (Invitrogen, USA). Cloned HIV-1 env 
sequences were screened by heteroduplex mobility as-
say (previously described by Delwart et al. [16]), and 
only those clones that were genetically distinct were se-
quenced using the ED31 primer to obtain the V3 region 
data. DNA sequences of cloned pol and env fragments 
(corresponding to 2135–3338 and 7017–7322 in HXB2, 
respectively) were determined and analysis was per-
formed using the Vector NTI suite of programs (Version 
9.0; InforMax, UK) and CLUSTALW. Potential N-linked 
glycosylation sites were identified using the N-glycosite 
program available on the HIV Sequence Database web-
site (http://www.hiv.lanl.gov/).
Phylogenetic Analyses
Phylogenetic and molecular evolutionary analyses were 
conducted using MEGA version 2.1 [17]. Estimations of 
genetic distance were made using MEGA with 1000 boot-
strap replicates. The statistical significance of differences 
in net charge distribution between tissues of the same 
patient was evaluated using an unpaired t-test. Drug re-
sistance and other mutations were identified using the 
Stanford HIV Drug Resistance Database (http://hivdb.
stanford.edu/). Co-receptor usage prediction for se-
quences was performed using the web PSSM software 
(http://ubik.microbiol.washington.edu/computing/
pssm/).
Sequence Data
The sequence data generated in this study were depos-
ited into GenBank under the accession numbers AY–
53552–AY653632 and AY874175–AY874233 for pol, and 
AY653633–AY653728 and AY874234–AY874280 for env 
sequences.
Results
Virus isolation and phenotypic characterization
We obtained a total of 80 HIV-1-infected tissue samples 
from 31 AIDS patients, seven tissues from three HIV-1in-
fected asymptomatic patients, and seven tissues from six 
uninfected control patients (Table 1). The HIV-1-positive 
groups had a younger average age, and higher, more 
variable postmortem interval than the HIV-1-negative 
controls. The successful isolation of HIV-1 from these tis-
sues correlated with the disease status and with the tis-
Figure 1. Phylogenetic analysis and characterization of HIV-1 
env sequences. (a) Neighbor-joining phylogenetic tree (1000 
bootstrapped replicates) of deduced HIV-1 env amino acid se-
quences (265–366 HIVHXB2 Env) isolated from brain, choroid 
plexus (CPx), and spleen tissues of cases A–E. Circles indicate 
sequences from patient A, diamonds indicate sequences from 
patient B, squares indicate sequences from patient C, triangles 
indicate sequences from patient D, and inverted triangles indi-
cate sequences from patient E. Open symbols represent brain 
sequences, grey symbols represent CPx sequences, and black 
symbols represent spleen sequences. Numbers on each branch 
indicate bootstrap values. NL4-3 (M19921) was included as 
an outgroup. (b–f) Alignments of deduced env amino acid se-
quence of molecular clones from brain (Br), choroid plexus 
(CPx), and spleen (Sp) tissues of patients A–E (panels b–f, re-
spectively) representing residues 265–366 of HIVHXB2 Env. 
*Only one sequence was obtained as a result of a lack of tissue 
sample. # Number of clones sequenced with the sequence indi-
cated; periods (.) indicate gaps in the alignment, dashes (—) in-
dicate identity with the consensus sequence, shaded sequences 
indicate potential N-linked glycosylation sites.
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sue source, but did not correlate with HAART treatment, 
brain pathology, postmortem interval or PCR amplifica-
tion for env sequences. Despite PCR detection of HIV-1 
in a large number of samples, we successfully cultured 
HIV-1 in only 19.4% of the AIDS patients from at least 
one tissue and none from the asymptomatic group. Virus 
was most frequently isolated from basal ganglia (27%), 
with a similar success from both CPx and spleen sam-
ples (18 and 12%), and was unsuccessful from frontal or 
temporal cortical tissues (Table 1). Of the six cases that 
yielded viable virus, the neuropathological changes in-
cluded: two with HIVE, (a) two with meningitis, and 
one each with lymphoma or white matter gliosis. The 
postmortem interval of these six patients averaged 10.8 h 
and ranged from 8 to 16 h.
Among the six virus-positive cases, three had viruses iso-
lated from all three tissues (brain, spleen, and CPx), and 
these isolates were further characterized (denoted A–C; 
Table 2). All brain and CPx virus isolates were exclusively 
macrophage tropic in vitro and preferentially utilized the 
CCR5 for viral entry. All spleen isolates were able to rep-
licate in primary macrophages and T-cell lines, and dis-
played preferential usage of the CCR5 and CXCR4
Figure 2. Observed mutations and phylogenetic analysis of HIV-1 pol sequences. (a and b) The presence of relevant resistance-asso-
ciated mutations at significant sites in pol for brain, choroid plexus (CPx), and spleen tissues of patients A–E compared with consen-
sus drug-naive subtype B sequence (WT). Only those mutations that occurred in more than one clone are reported. (a) Mutations 
found in protease region; (b) mutations in reverse transcriptase region. (c) Neighbor-joining phylogenetic tree (1,000 bootstrapped 
replicates) of deduced HIV-1 pol amino acid sequences (17–418 HIVHXB2 Pol) isolated from brain, CPx, and spleen tissues of cases 
A–E. Circles indicate sequences from patient A, diamonds indicate sequences from patient B, squares indicate sequences from pa-
tient C, triangles indicate sequences from patient D, and inverted triangles indicate sequences from patient E. Open symbols rep-
resent brain sequences, grey symbols represent CPx sequences, and black symbols represent spleen sequences. Numbers on each 
branch indicate bootstrap values. NL4-3 (M19921) was included as an outgroup.
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co-receptors. In cross-infection experiments of CXCR4 
and CCR5 co-receptor lines, we found that spleen virus 
was indeed a mixture of viruses rather than dual-tropic 
for both co-receptors. All viral isolates also exhibited 
multiple tissue-specific minor chemokine co-receptor us-
age in GHOST(3) cell lines (Table 2). The co-receptors uti-
lized by brain viral isolates included CCR2, CCR3, CCR4 
and CXCR6; all CPx isolates utilized the CCR3, CCR4, 
and CXCR4 co-receptors to a lesser extent than CCR5. 
Viral isolates from the spleen commonly utilized CCR3, 
CCR4, CCR6, CCR8 and CX3CR1.
Compartmentalization of HIV-1 env
The V3 region of env from five patients with amplifiable 
env sequences from three tissue compartments (Table 2) 
was chosen for genetic analyses because it contains se-
quences that are most indicative of viral tropism, espe-
cially co-receptor usage. All sequences obtained in this 
study were patient-specific, as sequences from each in-
dividual patient clustered together and contamination 
from laboratory strains was ruled out phylogenetically 
(Figure 1a). Each patient had env sequences that divided 
into at least two subgroups, indicating a level of tissue-
specific variation that was discrete, but phylogenetically 
related (Figure 1a). Three out of five patients’ brain and 
CPx sequences were more genetically similar to one an-
other than to spleen tissue when comparisons of the av-
erage intratissue genetic distance were used (data not 
shown). Patient E showed no compartmentalization, but 
did show two distinct lineages that contained sequences 
from all three tissues. Generally, for HIVE-positive indi-
viduals (A, B, D, and E), the intratissue genetic distance 
of env was highest in the spleen, the number of poten-
tial N-linked glycosylation sites were reduced in brain 
env sequences, and the V3 loop net charge was less posi-
tive when compared with spleen env sequences (Figures 
1b–d). Coreceptor usage prediction programmes found 
that those CPx sequences that showed great similarity to 
spleen sequences were also CXCR4-utilizing strains.
Compartmentalization of viral pol
Drug resistance mutations identified in the pol gene of vi-
ral isolates were determined by comparison with exist-
ing resistance sequences found in the Stanford drug re-
sistance database (Figures 2a and b). Although potential 
drug resistance mutations were detected in tissues from 
all patients studied, the purpose of analysing these pop-
ulations was also to examine the compartmentalization 
of viral pol sequences in comparison with env. As the pol 
gene is under strong selective pressure by antiretroviral 
drugs during treatment, whereas env is under immuno-
logical selective pressure, this comparison is warranted. 
Phylogenetic comparisons of amino acid sequences ob-
tained from the pol of HIV-1 isolates showed a similar 
grouping pattern as for env (Figure 2c), but with some 
notable differences. Generally, pol sequences from the 
brain grouped together for each subject, but in some in-
stances also showed significant similarity to spleen se-
quences. All five patients investigated had evidence of 
two pol genotype lineages that could be phylogenetically 
distinguished from each other, and in four out of five 
cases (A–D) this division was indicative of tissue com-
partmentalization. Furthermore, CPx virus commonly 
formed a unique group, but was more often related to 
the brain sequences than to those of peripheral origin. 
Interestingly, CPx sequences often showed extensively 
more G → A hypermutation that resulted in the intro-
duction of stop codons than other tissues, but these se-
quences were not used in subsequent analyses. Although 
most of the cases in this study were treated with HAART 
(case B history was unknown), specific details of their 
drug treatment histories were not available. However, 
based on sequence analysis of pol, all cases revealed mul-
tiple amino acid mutations that possibly conferred resis-
tance to antiretroviral drugs (Figures 2a and b). In addi-
tion, subject C showed significant sequence differences 
in the pol gene from spleen virus compared with those 
from the brain; a relationship that is distinct from the env 
sequences. Other areas of hypermutation in the reverse 
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transcriptase (RT) gene showed tissue-specific distribu-
tion (data not shown) but were not predictive of drug re-
sistance.
Discussion
The CPx is a highly vascularized CNS tissue that pro-
vides a barrier between the circulatory system and the 
CSF, and is responsible for the production and mainte-
nance of CSF. Because both blood and CSF contact the 
surfaces of the CPx, it is critical to understand the mech-
anisms whereby HIV-1 interacts with or infects the CPx. 
A recent report using pseudoviruses in mice [18] sug-
gested that HIV-1 accesses the CSF via a rapid transport 
process, possibly transcytosis through the CPx. How-
ever, during chronic disease, CSF viral load correlates 
with neurological disease progression [19–21], but it is 
unclear whether the origin of virus found in the CSF is 
from resident immune cells in the CSF and associated tis-
sues [22] or whether it is acquired from systemic sources 
[19, 20, 23, 24]. On the basis of its function as a barrier be-
tween various compartments, including the CSF, blood, 
and CNS, we proposed that the CPx could play a signif-
icant role in the bidirectional dissemination of HIV be-
tween the periphery and the CNS.
We previously identified infected cells in situ and iso-
lated HIV-1 sequences from CPx tissues [12, 25], but it 
was unknown whether the CPx contains productively 
infected cells. In the current study, we investigated the 
genotypic and phenotypic properties of primary HIV-1 
isolates derived from the spleen, CPx, and brain tissues. 
Successful viral isolation was low compared with the 
PCR detection of DNA sequences, possibly as a result 
of long postmortem intervals, low numbers of produc-
tively infected cells in the autopsy tissues, and the isola-
tion protocols employed.
Investigation of the env and pol genes of HIV-1 in tissues 
from AIDS patients showed that there was clear com-
partmentalization of sequences in the brain compared 
with the periphery, but this was dependent on disease 
progression and the effectiveness of HAART. Although 
the dataset is limited to tissues from five individuals, 
these findings clearly demonstrate that the HIV-1 pop-
ulation contained within the CPx includes, predictably, 
viruses from peripheral origin, and in addition, viruses 
from the CNS. Specific analyses of viral sequences found 
in the CPx tissue showed that, overall, they are more ge-
netically like those in the brain, but still harbor sequences 
similar to those in the periphery. These data are consis-
tent with our previous study of formalin-fixed CPx tis-
sues from four HIVE cases [12], and imply that the CPx is 
a tissue in which viruses or virus-infected cells from both 
peripheral and CNS sources can colocalize. This may be 
pertinent to neuropathogenesis because it is likely both 
to facilitate access of cytopathic or neuropathogenic 
variants to the CNS late in disease and to reseed archi-
val strains from the CNS into the periphery, such as that 
seen in studies of patients undergoing strategic therapy 
interruptions of HAART who had a recurrence of drug-
sensitive viruses [26–29].
The pol gene, an inherently functionally conserved gene, 
is targeted by most antiretroviral therapies. There is 
strong evolutionary pressure on pol to retain function 
and to overcome inhibition by antiretroviral drugs, re-
sulting in the emergence of replication-competent drug-
resistant viral strains. In this study of late-stage AIDS 
patients, there was no evidence of tissue compartmental-
ization of drug-resistance amino acid mutations in any 
of the cases studied; however, synonymous DNA poly-
morphisms were tissue-specific. In particular, our study 
shows that HIV-1 pol found in the CPx does evolve inde-
pendently, despite being genetically similar to a specific 
tissue compartment. Disease progression is likely to in-
fluence compartmentalization, and in severe immunode-
ficiency, as seen in case E, there is limited compartmen-
talization. Regardless of this, as highlighted by specific 
mutations, the CPx seems to harbor viruses with resis-
tance mutations similar to those found in other tissues.
Tissue compartmentalization of viral sequences occurs 
early, and the progenitor virus is thought to evolve in-
dependently within the unique selective microenviron-
ment [30, 31]. In the current study, the env gene of vi-
rus variants found in the CPx consisted of two genotypic 
lineages, indicating that there may be a cellular restric-
tion of HIV-1 in the CPx, presumably monocytes and T 
cells. Our analyses of pol and env genes suggest that each 
gene is affected independently. As a part of the innate 
immunity of the CNS, the CPx possesses many cell types 
that can be infected by HIV-1, and thus can provide an 
environment for the transfer of neurocytopathic isolates 
to monocytes and macrophages that traffic between the 
CPx stroma and CSF [32, 33]. Analysis of the phenotypic 
properties of HIV-1 isolated from the CPx revealed that 
all were non-syncytium inducing, macrophage tropic, 
and primarily utilized the CCR5 co-receptor for entry. 
Furthermore, in the two viral isolates from HIVE cases, 
there also existed CXCR4-tropic isolates and sequences 
in the CPx. As neurons and astrocytes are more vulner-
able to injury and death when exposed to CXCR4-tropic 
than CCR5-tropic envelopes in vitro, the presence of 
CXCR4 strains in the CPx could contribute to brain in-
jury [34, 35]. In addition, genotype results support the 
co-localization of macrophage tropic and X4 cytopathic 
isolates in the CPx, because some CPx env sequences in 
the CPx were similar to spleen sequences, and possessed 
a higher net V3 charge than brain sequences. This prop-
erty has been associated with CXCR4 usage, T-tropism, 
and syncytium-inducing phenotypes [36]. Although we 
have previously identified HIV-1-infected monocytes 
Co m P a r t m e n t a l i z a t i o n o f HiV-1 i n t H e Ce n t r a l ne r V o u s sy s t e m:  ro l e o f t H e CH o r o i d Pl e x u s  683
within the CPx stroma of AIDS patients [25], future stud-
ies will be needed to identify the specific CPx cell types 
and viral genotypes able to infect them. Nevertheless, it 
is clear that the colocalization of diverse viral genotypes 
and phenotypes occurs within the CPx.
The blood–CSF barrier is often overlooked in HIV-1 in-
fection, despite its probable role in entry into the CNS. 
This study demonstrates that the CPx is a tissue compart-
ment that contains replication-competent virus and may 
evolve distinct viral genotypes and phenotypes, partic-
ularly neurotoxic and drug-resistant viruses. Future in-
vestigation of the interplay between HIV-1 found in the 
brain, CSF, and CPx, and its relation to HAD and HIVE 
will clarify the significance of the CPx in AIDS neuro-
pathogenesis.
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